Sana Biotechnology Inc (SANA)
6.08
-1.07
(-14.96%)
USD |
NASDAQ |
Jun 14, 16:00
6.085
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Cash from Investing (TTM): 32.06M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 32.06M |
December 31, 2023 | 172.01M |
September 30, 2023 | 245.13M |
June 30, 2023 | 225.64M |
March 31, 2023 | 260.74M |
December 31, 2022 | 210.56M |
September 30, 2022 | 48.47M |
Date | Value |
---|---|
June 30, 2022 | -169.29M |
March 31, 2022 | -282.34M |
December 31, 2021 | -245.80M |
September 30, 2021 | -159.10M |
June 30, 2021 | -241.50M |
March 31, 2021 | -242.65M |
December 31, 2020 | -252.56M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-282.34M
Minimum
Mar 2022
260.74M
Maximum
Mar 2023
-28.47M
Average
-63.52M
Median
Cash from Investing (TTM) Benchmarks
Cytokinetics Inc | 106.40M |
Insmed Inc | 30.12M |
PetMed Express Inc | -40.67M |
Atea Pharmaceuticals Inc | 72.62M |
Prime Medicine Inc | -5.656M |